Top

Sleep and Breathing

Published in:

01-06-2019 | Sleep Breathing Physiology and Disorders • Original Article

Laryngopharyngeal motor dysfunction and obstructive sleep apnea in Parkinson’s disease

Authors: Christianne Martins Corrêa Silva Bahia, João Santos Pereira, Agnaldo José Lopes

Published in: Sleep and Breathing | Issue 2/2019

Abstract

Purpose

Obstructive sleep apnea (OSA) is a common sleep disorder in Parkinson’s disease (PD), but the relationship between these two conditions remains uncertain. Upper airway (UA) dysfunction in PD is well documented in some patients and is believed to be a reflex of the motor involvement of laryngopharyngeal muscles. The aim of this study is to determine whether UA dysfunction and laryngopharyngeal motor dysfunction (LMD) are involved in the obstructive phenomenon of OSA in PD.

Methods

Forty-eight PD patients underwent polysomnography for OSA diagnosis, functional evaluation of the UA by spirometry and a clinical protocol for analysis of laryngopharyngeal muscles and physical examination.

Results

Thirty-one participants (64.6%) fulfilled the criteria for OSA according to the International Classification of Sleep Disorders- third edition (at least respiratory disturbance index of five or higher per hour of sleep plus specific symptoms). UA obstruction was observed in 25% of participants and LMD in 60.4%. Among the clinical indicators of LMD, hypophonia was the most common (58.3%). Participants with LMD had a threefold greater chance of presenting with OSA than those without LMD did (OR = 3.49; 95% CI, 1.01–12.1; p = 0.044). Individuals with LMD had more UA dysfunction (37.9 vs 10.5%, p = 0.037), higher scores on UPDRS III (20 vs 15, p = 0.0005) and the Hoehn-Yahr scale (2.5 vs 2.0, p = 0.008), and higher frequencies of postural changes (51.7 vs 21.1%, p = 0.033) and motor phenomena (65.5 vs 31.6%, p = 0.021). Obesity, snoring, neck circumference, and the Mallampati score did not correlate with OSA in PD.

Conclusion

LMD should be considered a factor that is involved in the obstructive phenomenon of UA in patients with OSA and PD.

Halliday G, Lees A, Stern M (2011) Milestones in Parkinson’s disease-clinical and pathologic features. Mov Disord 26:1015–1021. https://doi.org/10.1002/mds.23669 CrossRefPubMed

Cochen De Cock V, Vidailhet M, Arnulf I (2008) Sleep disturbances in patients with parkinsonism. Nat Clin Pract Neurol 4:254–266. https://doi.org/10.1038/ncpneuro0775 CrossRef

Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M, Sanchez-Valle R, Vilaseca I, Lomeña F, Vilas D, Lladó A, Gaig C, Santamaria J (2013) Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol 12:443–453. https://doi.org/10.1016/S1474-4422(13)70056-5 CrossRefPubMed

De Lau LML, Breteler MMB (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5:525–535. https://doi.org/10.1016/S1474-4422(06)70471-9 CrossRef

Tufik S, Santos-Silva R, Taddei JA, Bittencourt LR (2010) Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Med 11:441–446. https://doi.org/10.1016/j.sleep.2009.10.005 CrossRefPubMed

da Silva-Júnior FP, do Prado GF, Barbosa ER, Tufik S, Togeiro SM (2014) Sleep disordered breathing in Parkinson’s disease: a critical appraisal. Sleep Med Rev 18:173–178. https://doi.org/10.1016/j.smrv.2013.04.005 CrossRefPubMed

Schwartz AR, Patil SP, Laffan AM, Polotsky V, Schneider H, Smith PL (2008) Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc 5:185–192. https://doi.org/10.1513/pats.200708-137MG CrossRefPubMedPubMedCentral

Vincken WG, Gauthier SG, Dollfuss RE, Hanson RE, Darauay CM, Cosio MG (1984) Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation. N Engl J Med 311:438–442. https://doi.org/10.1056/NEJM198408163110704 CrossRefPubMed

Sabaté M, González I, Ruperez F, Rodríguez M (1996) Obstructive and restrictive pulmonary dysfunctions in Parkinson’s disease. J Neurol Sci 138:114–119. https://doi.org/10.1016/0022-510X(96)00003-2 CrossRefPubMed

10.

Shill H, Stacy M (2002) Respiratory complications of Parkinson’s disease. Semin Respir Crit Care Med 23:261–265. https://doi.org/10.1055/s-2002-33034 CrossRefPubMed

11.

Herer B, Arnulf I, Housset B (2001) Effects of levodopa on pulmonary function in Parkinson’s disease. Chest 119:387–393. https://doi.org/10.1378/chest.119.2.387 CrossRefPubMed

12.

Sawczuk A, Mosier KM (2001) Neural control of tongue movement with respect to respiration and swallowing. Crit Rev Oral Biol Med 12:18–37. https://doi.org/10.1177/10454411010120010101 CrossRefPubMed

13.

Mu L, Sobotka S, Chen J, Su H, Sanders I, Adler CH, Shill HA, Caviness JN, Samanta JE, Beach TG, Arizona Parkinson’s Disease Consortium (2013) Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease. J Neuropathol Exp Neurol 72:119–129. https://doi.org/10.1097/NEN.0b013e3182801cde CrossRefPubMedPubMedCentral

14.

Baker KK, Ramig LO, Luschei ES, Smith ME (1998) Thyroarytenoid muscle activity associated with hypophonia in Parkinson disease and aging. Neurology 51:1592–1598. https://doi.org/10.1212/WNL.51.6.1592 CrossRefPubMed

15.

Cochen De Cock V, Abouda M, Leu S, Oudiette D, Roze E, Vidailhet M, Similowski T, Arnulf I (2010) Is obstructive sleep apnea a problem in Parkinson’s disease? Sleep Med 11:247–252. https://doi.org/10.1016/j.sleep.2009.05.008 CrossRefPubMed

16.

Maria B, Sophia S, Michalis M, Charalampos L, Andreas P, John ME, Nikolaos SM (2003) Sleep breathing disorders in patients with idiopathic Parkinson’s disease. Respir Med 97:1151–1157. https://doi.org/10.1016/S0954-6111(03)00188-4 CrossRefPubMed

17.

Neikrug AB, Maglione JE, Liu L, Natarajan L, Avanzino JA, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S (2013) Effects of sleep disorders on the non-motor symptoms of Parkinson disease. J Clin Sleep Med 9:1119–1129. https://doi.org/10.5664/jcsm.3148 CrossRefPubMedPubMedCentral

18.

Trotti LM, Bliwise DL (2010) No increased risk of obstructive sleep apnea in Parkinson’s disease. Mov Disord 25:2246–2249. https://doi.org/10.1002/mds.23231 CrossRefPubMedPubMedCentral

19.

Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184. https://doi.org/10.1136/jnnp.55.3.181 CrossRefPubMedPubMedCentral

20.

Brazilian Institute of Geography and Statistics (2011). Ethno-racial characteristics of the population – a study of the 2008 classification categories of color or race. Resource https://biblioteca.ibge.gov.br/visualizacao/livros/liv49891.pdf. Accessed 20 May 2018

21.

Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25:2649–2653. https://doi.org/10.1002/mds.23429 CrossRefPubMed

22.

Bertolazi AN, Fagondes SC, Hoff LS, Pedro VD, Menna Barreto SSM, Johns MW (2009) Portuguese-language version of the Epworth sleepiness scale: validation for use in Brazil. J Bras Pneumol 35:877–883. https://doi.org/10.1590/S1806-37132009000900009 CrossRefPubMed

23.

Berry RB, Brooks R, Gramaldo CE, et al For the American Academy of Sleep Medicine (2017) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Version 2.4 American Academy of Sleep Medicine, Darien, Illinois

24.

American Academy of Sleep Medicine (2014) International classification of sleep disorders, 3rd edn. American Academy of Sleep Medicine, Darien, Illinois

25.

Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force (2005) Standardisation of spirometry. Eur Respir J 26:319–338. https://doi.org/10.1183/09031936.05.00034805 CrossRefPubMed

26.

Pereira CAC, Sato T, Rodrigues SC (2007) New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 33:397–406. https://doi.org/10.1590/S1806-37132007000400008 CrossRefPubMed

27.

Valko PO, Hauser S, Sommerauer M, Werth E, Baumann CR (2014) Observations on sleep-disordered breathing in idiopathic Parkinson’s disease. PLoS One 9:e100828. https://doi.org/10.1371/journal.pone.0100828 CrossRefPubMedPubMedCentral

28.

Wang Y, Shao WB, Gao L, Lu J, Gu H, Sun LH (2014) Abnormal pulmonary function and respiratory muscle strength findings in Chinese patients with Parkinson’s disease and multiple system atrophy: comparison with normal elderly. PLoS One 9:e116123CrossRefPubMedPubMedCentral

29.

Modrykamien AM, Gudavalli R, McCarthy K, Liu X, Stoller JK (2009) Detection of upper airway obstruction with spirometry results and the flow-volume loop: a comparison of quantitative and visual inspection criteria. Respir Care 54:474–479PubMed

30.

Hoffstein V, Oliver Z (2003) Pulmonary function and sleep apnea. Sleep Breath 7:159–165. https://doi.org/10.1007/s11325-003-0159-8 CrossRefPubMed

31.

Yoshida T, Kono I, Yoshikawa K, Hashimoto H, Harada H, Nakagawa M (2003) Improvement of sleep hypopnea by antiparkinsonian drugs in a patient with Parkinson’s disease: a polysomnographic study. Intern Med 42:1135–1138. https://doi.org/10.2169/internalmedicine.42.1135 CrossRefPubMed

32.

Saletu M, Anderer P, Saletu B, Hauer C, Mandl M, Oberndorfer S, Zoghlami A, Saletu-Zyhlarz G (2000) Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variables. Neuropsychobiology 41:190–199. https://doi.org/10.1159/000026659 CrossRefPubMed

33.

Zamarron C, García Paz VC, Riveiro A (2008) Obstructive sleep apnea syndrome is a systemic disease. Current evidence. Eur J Intern Med 19:390–398. https://doi.org/10.1016/j.ejim.2007.12.006 CrossRefPubMed

34.

Chen JC, Tsai TY, Li CY, Hwang JH (2015) Obstructive sleep apnea and risk of Parkinson’s disease: a population-based cohort study. J Sleep Res 24:432–437. https://doi.org/10.1111/jsr.12289 CrossRefPubMed

Title: Laryngopharyngeal motor dysfunction and obstructive sleep apnea in Parkinson’s disease
Authors: Christianne Martins Corrêa Silva Bahia
João Santos Pereira
Agnaldo José Lopes
Publication date: 01-06-2019
Publisher: Springer International Publishing
Published in: Sleep and Breathing / Issue 2/2019
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-018-1729-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2019

Sleep quality in survivors of critical illness: practical shortcomings unresolved

Mechanisms of vascular endothelial cell injury in response to intermittent and/or continuous hypoxia exposure and protective effects of anti-inflammatory and anti-oxidant agents

The use of mandibular advancement devices in obstructive sleep apnea: a proven and effective therapy

Seasonality of bruxism: evidence from Google Trends

Postural and vestibular changes related to CPAP treatment in moderate-to-severe OSA patients: a 12-month longitudinal study

Overexpression of filamin c in chronic intermittent hypoxia-induced cardiomyocyte apoptosis is a potential cardioprotective target for obstructive sleep apnea

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials